Legal & General Group Plc - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 174 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$999,317
-17.5%
219,630
+27.7%
0.00%
Q2 2023$1,210,719
+63.1%
171,977
+41.6%
0.00%
Q1 2023$742,236
-9.9%
121,479
-5.7%
0.00%
Q4 2022$823,524
-29.8%
128,877
+5.2%
0.00%
Q3 2022$1,173,000
-15.7%
122,501
-2.9%
0.00%
Q2 2022$1,392,000
-34.8%
126,142
-1.6%
0.00%
-100.0%
Q1 2022$2,134,000
-11.9%
128,192
+1.0%
0.00%0.0%
Q4 2021$2,423,000
-11.1%
126,888
+14.8%
0.00%0.0%
Q3 2021$2,726,000
+22.7%
110,561
+29.5%
0.00%0.0%
Q2 2021$2,222,000
-25.3%
85,381
-9.1%
0.00%0.0%
Q1 2021$2,975,000
-31.2%
93,972
+0.8%
0.00%
-50.0%
Q4 2020$4,327,000
+17.5%
93,268
-16.6%
0.00%0.0%
Q3 2020$3,682,000
+19.6%
111,852
-0.3%
0.00%
+100.0%
Q2 2020$3,079,000
+27.4%
112,167
+38.9%
0.00%0.0%
Q1 2020$2,417,000
+27.5%
80,747
+18.0%
0.00%0.0%
Q4 2019$1,895,000
+64.2%
68,455
+8.0%
0.00%0.0%
Q3 2019$1,154,000
+105.7%
63,397
+177.5%
0.00%
Q2 2019$561,000
+204.9%
22,846
+18.0%
0.00%
Q1 2019$184,000
+10.8%
19,362
+2.6%
0.00%
Q4 2018$166,000
+12.9%
18,863
+44.3%
0.00%
Q3 2018$147,000
-12.0%
13,0690.0%0.00%
Q2 2018$167,000
-28.9%
13,069
-5.9%
0.00%
Q1 2018$235,000
+92.6%
13,885
-7.7%
0.00%
Q4 2017$122,000
+9.9%
15,050
+6.4%
0.00%
Q3 2017$111,000
+7.8%
14,1430.0%0.00%
Q2 2017$103,00014,1430.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,674,299$65,948,0005.28%
Ghost Tree Capital, LLC 700,000$17,262,0005.05%
Perceptive Advisors 11,489,772$283,337,0004.12%
Prosight Management, LP 274,761$6,776,0003.73%
Fairmount Funds Management LLC 389,588$9,607,0003.49%
Avoro Capital Advisors LLC 8,500,000$209,610,0003.29%
ACUTA CAPITAL PARTNERS, LLC 374,495$9,235,0003.26%
Ally Bridge Group (NY) LLC 406,986$10,036,0002.95%
Parametrica Management Ltd 146,362$3,609,0002.70%
COMMODORE CAPITAL LP 362,869$8,948,0002.36%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders